250 related articles for article (PubMed ID: 7542384)
1. In vitro and ex vivo expression of nucleolar proteins B23 and p120 in benign and malignant epithelial lesions of the prostate.
Bocker T; Bittinger A; Wieland W; Buettner R; Fauser G; Hofstaedter F; Rüschoff J
Mod Pathol; 1995 Apr; 8(3):226-31. PubMed ID: 7542384
[TBL] [Abstract][Full Text] [Related]
2. [In vivo and ex vivo expression of nucleolar proliferation-associated antigens (p120, B23) in the prostate].
Rüschoff J; Bocker T; Buettner R; Bittinger A; Wieland W; Hofstaedter F
Verh Dtsch Ges Pathol; 1993; 77():103-6. PubMed ID: 7511264
[TBL] [Abstract][Full Text] [Related]
3. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between the nucleolar organizer region in adenocarcinoma of the prostate and the Gleason system].
Sentinelli S; Pizzuti V; Rondanelli E; Viggiani F; Paolini R
Pathologica; 1992; 84(1089):49-55. PubMed ID: 1379709
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J
Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
Botticelli AR; Casali AM; Botticelli L; Zaffe D
Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
[TBL] [Abstract][Full Text] [Related]
8. Intranucleolar localization of human proliferating cell nucleolar antigen p120.
Ochs RL; Reilly MT; Freeman JW; Busch H
Cancer Res; 1988 Nov; 48(22):6523-9. PubMed ID: 3052805
[TBL] [Abstract][Full Text] [Related]
9. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
10. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
Mirtti T; Alanen K; Kallajoki M; Rinne A; Söderström KO
Prostate; 2003 Mar; 54(4):290-8. PubMed ID: 12539227
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
Pflug BR; Onoda M; Lynch JH; Djakiew D
Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
[TBL] [Abstract][Full Text] [Related]
14. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
15. Keratin patterns in prostatic hyperplasia and adenocarcinoma.
Svanholm H; Nielsen B; Starklint H
APMIS Suppl; 1988; 4():100-8. PubMed ID: 2465010
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.
Chandler JD; Williams ED; Slavin JL; Best JD; Rogers S
Cancer; 2003 Apr; 97(8):2035-42. PubMed ID: 12673735
[TBL] [Abstract][Full Text] [Related]
17. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in cancerous and benign prostatic tissue.
Hudolin T; Juretic A; Spagnoli GC; Pasini J; Bandic D; Heberer M; Kosicek M; Cacic M
Prostate; 2006 Jan; 66(1):13-8. PubMed ID: 16114059
[TBL] [Abstract][Full Text] [Related]
19. A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal.
Walensky LD; Coffey DS; Chen TH; Wu TC; Pasternack GR
Cancer Res; 1993 Oct; 53(19):4720-6. PubMed ID: 7691403
[TBL] [Abstract][Full Text] [Related]
20. The quantity of nucleolar proteins nucleolin and protein B23 is related to cell doubling time in human cancer cells.
Derenzini M; Sirri V; Trerè D; Ochs RL
Lab Invest; 1995 Oct; 73(4):497-502. PubMed ID: 7474921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
